To improve model sensitivity, future work should integrate multi-modal data, such as genomics (e.g., 9p21, PITX2), imaging markers (e.g., white matter lesions), and real-time inputs from wearables, to capture stroke risk more comprehensively (139, 227). This evidence concerns the gene PITX2 and stroke disorder.